India, October 6, 2016: “Biosimilars presents a $240
Billion global opportunity for Indian Pharmaceuticals Industry while
domestic market is expected to cross $40 Billion by 2030 ” says
ASSOCHAM-SATHGURU Report released by Prof. D. Swaminadhan, President
& Director General, Jawaharlal Nehru Institute of Advanced Studies
(JNIAS) at ASSOCHAM-Department of Pharmaceuticals Conference on
↧